Laetitia Marzi

532 total citations
8 papers, 419 citations indexed

About

Laetitia Marzi is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Laetitia Marzi has authored 8 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Laetitia Marzi's work include Cancer therapeutics and mechanisms (5 papers), DNA Repair Mechanisms (3 papers) and Lung Cancer Research Studies (2 papers). Laetitia Marzi is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), DNA Repair Mechanisms (3 papers) and Lung Cancer Research Studies (2 papers). Laetitia Marzi collaborates with scholars based in United States, France and Spain. Laetitia Marzi's co-authors include Pierre Martineau, Céline Gongora, Vincent Denis, Maguy Del Rio, Annick Causse, Salomé Paillas, Nadia Vezzio-Vié, Yves Pommier, Yoshihiro Urade and Brigitte Moniot and has published in prestigious journals such as Development, Cancer Research and Clinical Cancer Research.

In The Last Decade

Laetitia Marzi

8 papers receiving 414 citations

Peers

Laetitia Marzi

MB

ONCOL

GENET

RM

CR

Zannel Blanchard United States

Marie‐Line Puiffe France

Marie Villedieu France

Monika Lamparska‐Przybysz Poland

Gourish Mondal United States

Elisabeth Werner Rönnerman Sweden

Hiroyuki Kouji Japan

Thippeswamy Gulappa United States

Zhengfeng Wang China

Yu‐Chun Weng Taiwan

Zannel Blanchard United States

Laetitia Marzi

183 ×0.6

MB

110 ×0.8

ONCOL

83 ×0.8

GENET

54 ×0.7

RM

100 ×2.0

CR

Citations per year, relative to Laetitia Marzi Laetitia Marzi (= 1×) peers Zannel Blanchard

Countries citing papers authored by Laetitia Marzi

Since Specialization

Citations

This map shows the geographic impact of Laetitia Marzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laetitia Marzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laetitia Marzi more than expected).

Fields of papers citing papers by Laetitia Marzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laetitia Marzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laetitia Marzi. The network helps show where Laetitia Marzi may publish in the future.

Co-authorship network of co-authors of Laetitia Marzi

This figure shows the co-authorship network connecting the top 25 collaborators of Laetitia Marzi. A scholar is included among the top collaborators of Laetitia Marzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laetitia Marzi. Laetitia Marzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Marzi, Laetitia, et al.. (2020). The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2. Molecular Cancer Therapeutics. 19(8). 1589–1597. 11 indexed citations

2.

Marzi, Laetitia, Ludmila Szabova, Zoë Weaver Ohler, et al.. (2019). The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib. Clinical Cancer Research. 25(20). 6206–6216. 43 indexed citations

3.

Marzi, Laetitia, Keli Agama, Junko Murai, et al.. (2018). Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors. Molecular Cancer Therapeutics. 17(8). 1694–1704. 32 indexed citations

4.

Marzi, Laetitia, Keli Agama, Zoë Weaver Ohler, et al.. (2017). Abstract 2794: Indotecan (LMP400), imidotecan (LMP776) and LMP744: A new class of non-camptothecin Top1 inhibitors selective for homologous recombination deficient (HRD) cells. Cancer Research. 77(13_Supplement). 2794–2794. 2 indexed citations

5.

Marzi, Laetitia, Nadia Vié, Diégo Tosi, et al.. (2016). FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer. British Journal of Cancer. 115(10). 1223–1233. 44 indexed citations

6.

Paillas, Salomé, Annick Causse, Laetitia Marzi, et al.. (2012). MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy. 8(7). 1098–1112. 73 indexed citations

7.

Paillas, Salomé, Florence Boissière‐Michot, Frédéric Bibeau, et al.. (2010). Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma. Cancer Research. 71(3). 1041–1049. 76 indexed citations

8.

Moniot, Brigitte, Francisco J. Barrionuevo, Gerd Scherer, et al.. (2009). The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation. Development. 136(11). 1813–1821. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact